학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 21건 | 목록 1~20
Academic Journal
SEMICONDUCTOR SCIENCE AND TECHNOLOGY; JUL 1996, 11 7, p989-p995, 7p.
Academic Journal
MATERIALS SCIENCE AND ENGINEERING B-SOLID STATE MATERIALS FOR ADVANCED TECHNOLOGY; DEC 1994, 28 1-3, p134-p137, 4p.
Academic Journal
SEMICONDUCTOR SCIENCE AND TECHNOLOGY; MAY 1994, 9 5, p1138-p1142, 5p.
Academic Journal
JOURNAL OF CRYSTAL GROWTH; JUL 1994, 140 3-4, p426-p428, 3p.
Academic Journal
Stepanek JJ; Ruhr-Universität Bochum, Applied Microbiology, Bochum, Germany.; Schäkermann S; Ruhr-Universität Bochum, Applied Microbiology, Bochum, Germany.; Wenzel M; Ruhr-Universität Bochum, Applied Microbiology, Bochum, Germany.; Prochnow P; Ruhr-Universität Bochum, Applied Microbiology, Bochum, Germany.; Bandow JE; Ruhr-Universität Bochum, Applied Microbiology, Bochum, Germany. julia.bandow@rub.de.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101298608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1862-8354 (Electronic) Linking ISSN: 18628346 NLM ISO Abbreviation: Proteomics Clin Appl Subsets: MEDLINE
Academic Journal
Wenzel M; Applied Microbiology, Ruhr University Bochum, Universitätsstrasse 150, 44801 Bochum (Germany).; Senges CHZhang JSuleman SNguyen MKumar PChiriac AIStepanek JJRaatschen NMay CKrämer USahl HGStraus SKBandow JE
Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE
Academic Journal
Senges CHR; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Stepanek JJ; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Wenzel M; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Raatschen N; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Ay Ü; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Märtens Y; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Prochnow P; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Vázquez Hernández M; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Yayci A; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Schubert B; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Janzing NBM; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Warmuth HL; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Kozik M; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Bongard J; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Alumasa JN; Biochemistry and Molecular Biology, Pennsylvania State University, State College, Pennsylvania, USA.; Albada B; Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.; Penkova M; Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.; Lukežič T; Acies Bio, Ljubljana, Slovenia.; Sorto NA; Department of Chemistry, University of California-Davis, Davis, California, USA.; Lorenz N; Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.; Miller RG; Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.; Zhu B; Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Göttingen, Germany.; Benda M; Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Göttingen, Germany.; Stülke J; Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Göttingen, Germany.; Schäkermann S; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.; Leichert LI; Microbial Biochemistry, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.; Scheinpflug K; Peptide Lipid Interactions, Leibniz Institute for Molecular Pharmacology, Berlin, Germany.; Brötz-Oesterhelt H; Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.; Hertweck C; Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.; Shaw JT; Department of Chemistry, University of California-Davis, Davis, California, USA.; Petković H; Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.; Brunel JM; UMR MD1, Membranes et Cibles Thérapeutiques, Faculté de Pharmacie U1261 INSERM, Aix-Marseille Université, Marseille, France.; Keiler KC; Biochemistry and Molecular Biology, Pennsylvania State University, State College, Pennsylvania, USA.; Metzler-Nolte N; Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.; Bandow JE; Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany julia.bandow@rub.de.
Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Academic Journal
Krewing M; 1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.; Stepanek JJ; 1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.; Cremers C; 4 Molecular, Cellular, and Developmental Biology, University of Michigan , Ann Arbor, MI , USA.; Lackmann JW; 1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.; Schubert B; 1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.; Müller A; 2 Microbial Biochemistry, Faculty of Medicine, Ruhr University Bochum , Bochum , Germany.; Awakowicz P; 3 Electrical Engineering and Plasma Technology, Faculty of Electrical Engineering and Information Sciences, Ruhr University Bochum , Bochum , Germany.; Leichert LIO; 2 Microbial Biochemistry, Faculty of Medicine, Ruhr University Bochum , Bochum , Germany.; Jakob U; 4 Molecular, Cellular, and Developmental Biology, University of Michigan , Ann Arbor, MI , USA.; Bandow JE; 1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.
Publisher: Royal Society Country of Publication: England NLM ID: 101217269 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-5662 (Electronic) Linking ISSN: 17425662 NLM ISO Abbreviation: J R Soc Interface Subsets: MEDLINE
Academic Journal
Wenzel M; Applied Microbiology, Ruhr University Bochum Bochum, Germany.; Prochnow P; Applied Microbiology, Ruhr University Bochum Bochum, Germany.; Mowbray C; Institute for Cell and Molecular Biosciences, Newcastle University Newcastle upon Tyne, UK.; Vuong C; AiCuris Anti-infective Cures GmbH Wuppertal, Germany.; Höxtermann S; Clinic for Dermatology and Allergology, St. Josef Hospital Bochum, Germany.; Stepanek JJ; Applied Microbiology, Ruhr University Bochum Bochum, Germany.; Albada HB; Chair of Inorganic Chemistry I - Bioinorganic Chemistry, Ruhr University Bochum Bochum, Germany.; Hall J; Institute for Cell and Molecular Biosciences, Newcastle University Newcastle upon Tyne, UK.; Metzler-Nolte N; Chair of Inorganic Chemistry I - Bioinorganic Chemistry, Ruhr University Bochum Bochum, Germany.; Bandow JE; Applied Microbiology, Ruhr University Bochum Bochum, Germany.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Academic Journal
Stepanek JJ; Ruhr University Bochum, Applied Microbiology, Universitätsstraße 150, 44801 Bochum, Germany.; Lukežič T; ACIES BIO, Tehnoloski park 21, 1000 Ljubljana, Slovenia.; Teichert I; Ruhr University Bochum, Lehrstuhl für Allgemeine und Molekulare Botanik, Universitätsstraße 150, 44801 Bochum, Germany.; Petković H; ACIES BIO, Tehnoloski park 21, 1000 Ljubljana, Slovenia.; Bandow JE; Ruhr University Bochum, Applied Microbiology, Universitätsstraße 150, 44801 Bochum, Germany. Electronic address: julia.bandow@rub.de.
Publisher: Elsevier Pub. Co Country of Publication: Netherlands NLM ID: 0217513 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-3002 (Print) Linking ISSN: 00063002 NLM ISO Abbreviation: Biochim Biophys Acta Subsets: MEDLINE
Academic Journal
Albuquerque LJ; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC , Santo André 09210-170, Brazil.; Annes K; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC , Santo André 09210-170, Brazil.; Milazzotto MP; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC , Santo André 09210-170, Brazil.; Mattei B; Departamento de Biofísica, Universidade Federal de São Paulo , São Paulo 04021-001, Brazil.; Riske KA; Departamento de Biofísica, Universidade Federal de São Paulo , São Paulo 04021-001, Brazil.; Jäger E; Institute of Macromolecular Chemistry AS CR , 162 06 Prague, Czech Republic.; Pánek J; Institute of Macromolecular Chemistry AS CR , 162 06 Prague, Czech Republic.; Štěpánek P; Institute of Macromolecular Chemistry AS CR , 162 06 Prague, Czech Republic.; Kapusta P; J. Heyrovsky Institute of Physical Chemistry, 182 23 Prague, Czech Republic.; Muraro PI; Departamento de Química, Universidade Federal de Santa Maria , Santa Maria 97105-900, Brazil.; De Freitas AG; Departamento de Química, Universidade Federal de Santa Maria , Santa Maria 97105-900, Brazil.; Schmidt V; Departamento de Química, Universidade Federal de Santa Maria , Santa Maria 97105-900, Brazil.; Giacomelli C; Departamento de Química, Universidade Federal de Santa Maria , Santa Maria 97105-900, Brazil.; Bonvent JJ; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC , Santo André 09210-170, Brazil.; Giacomelli FC; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC , Santo André 09210-170, Brazil.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9882736 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5827 (Electronic) Linking ISSN: 07437463 NLM ISO Abbreviation: Langmuir Subsets: MEDLINE
Academic Journal
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Claes B; Biocartis NV, 2800 Mechelen, Belgium.; Huang HJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Falchook GS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA.; Devogelaere B; Biocartis NV, 2800 Mechelen, Belgium.; Cartagenia, 3001 Leuven, Belgium.; Kockx M; HistoGeneX NV, 2600 Berchem, Belgium.; Bempt IV; HistoGeneX NV, 2600 Berchem, Belgium.; Reijans M; Biocartis NV, 2800 Mechelen, Belgium.; Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Holley VR; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Stepanek VM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Kopetz ES; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Luthra R; Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Sablon E; Biocartis NV, 2800 Mechelen, Belgium.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Maertens G; Biocartis NV, 2800 Mechelen, Belgium.; Kurzrock R; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: fjanku@mdanderson.org.; Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Falchook GS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Stepanek VM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Moulder SL; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Luthra R; Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Broaddus RR; Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Kurzrock R; Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Ganesan P; Corresponding Author: Filip Janku, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, FC8.2018, Box 0455, Houston, Texas 77030. fjanku@mdanderson.org.; Janku FNaing AHong DSTsimberidou AMFalchook GSWheler JJPiha-Paul SAFu SStepanek VMLee JJLuthra ROverman MJKopetz ESWolff RAKurzrock R
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Wenzel M; Biology of Microorganisms and ‡Bioinorganic Chemistry, Ruhr University Bochum , Bochum, Germany.; Patra MSenges CHOtt IStepanek JJPinto AProchnow PVuong CLangklotz SMetzler-Nolte NBandow JE
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE
Academic Journal
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. fjanku@mdanderson.org; Wheler JJNaing AFalchook GSHong DSStepanek VMFu SPiha-Paul SALee JJLuthra RTsimberidou AMKurzrock R
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. fjanku@mdanderson.org; Wheler JJNaing AStepanek VMFalchook GSFu SGarrido-Laguna ITsimberidou AMPiha-Paul SAMoulder SLLee JJLuthra RHong DSKurzrock R
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
Roblyer D; Rice University, Department of Bioengineering, Houston, TX 77251-1892, USA.; Kurachi CStepanek VSchwarz RAWilliams MDEl-Naggar AKLee JJGillenwater AMRichards-Kortum R
Publisher: Published by SPIE--the International Society for Optical Engineering in cooperation with International Biomedical Optics Society Country of Publication: United States NLM ID: 9605853 Publication Model: Print Cited Medium: Internet ISSN: 1560-2281 (Electronic) Linking ISSN: 10833668 NLM ISO Abbreviation: J Biomed Opt Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Stepanek JJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어